Eric Jacobsen
Impact in
- Pathology and Forensic Medicine top 0.1%
- Lymphoma Diagnosis and Treatment
- Oncology top 0.2%
- CAR-T cell therapy research
- Viral-associated cancers and disorders
Papers in
-
- Lymphoma Diagnosis and Treatment 125
- Genetics 56
- Chronic Lymphocytic Leukemia Research 55
- Co-authors
- Arnold S. Freedman (21 shared papers)Steven M. Horwitz (12 shared papers)Nancy L. Bartlett (12 shared papers)Ranjana H. Advani (13 shared papers)Ivana N. Micallef (5 shared papers)Mark Warren Clemens (1 shared paper)David Christopher Fisher (42 shared papers)Owen A. O’Connor (8 shared papers)
- Journals
- Blood (55 papers)Hematological Oncology (12 papers)Journal of Clinical Oncology (10 papers)Blood Advances (9 papers)British Journal of Haematology (7 papers)
- Partner nations
- United StatesItalyFrance
In The Last Decade
Eric Jacobsen
183 papers receiving 14.0k citations
Eric Jacobsen's Hit Papers
Peers
Comparison fields: 5 of 138
- Pathology and Forensic Medicine 5.6k
- Oncology 7.7k
- Genetics 2.3k
- Hematology 1.5k
- Immunology 2.8k
Countries citing papers authored by Eric Jacobsen
This map shows the geographic impact of Eric Jacobsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Jacobsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Jacobsen more than expected).
Fields of papers citing papers by Eric Jacobsen
This network shows the impact of papers produced by Eric Jacobsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Jacobsen. The network helps show where Eric Jacobsen may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Jacobsen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 193 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma Hit paper breakdown → | 2017 | 4744 |
| 2 | Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma Hit paper breakdown → | 2009 | 573 |
| 3 | Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial Hit paper breakdown → | 2018 | 554 |
| 4 | Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study Hit paper breakdown → | 2011 | 516 |
| 5 | Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma Hit paper breakdown → | 2017 | 395 |
| 6 | Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease Hit paper breakdown → | 2018 | 381 |
| 7 | Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial Hit paper breakdown → | 2017 | 360 |
| 8 | 2013 | 340 | |
| 9 | 2014 | 284 | |
| 10 | 2010 | 264 | |
| 11 | 2016 | 258 | |
| 12 | Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era Hit paper breakdown → | 2020 | 258 |
| 13 | 2015 | 243 | |
| 14 | 2019 | 231 | |
| 15 | 2019 | 227 | |
| 16 | 2017 | 180 | |
| 17 | 2014 | 170 | |
| 18 | 2019 | 169 | |
| 19 | 2008 | 156 | |
| 20 | 2016 | 155 |
About Eric Jacobsen
Eric Jacobsen is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Immunology and Dermatology, having authored 193 papers that have together received 14.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (125 papers), Chronic Lymphocytic Leukemia Research (55 papers), CAR-T cell therapy research (42 papers), Viral-associated cancers and disorders (29 papers), Cutaneous lymphoproliferative disorders research (23 papers), T-cell and Retrovirus Studies (16 papers), Histiocytic Disorders and Treatments (14 papers) and Immune Cell Function and Interaction (13 papers). The work is most often cited by research in Pathology and Forensic Medicine (5.6k citations), Oncology (7.7k citations), Genetics (2.3k citations), Hematology (1.5k citations) and Immunology (2.8k citations). Eric Jacobsen has collaborated with scholars based in United States, Italy and France. Frequent co-authors include Arnold S. Freedman, Steven M. Horwitz, Nancy L. Bartlett, Ranjana H. Advani, Ivana N. Micallef, Mark Warren Clemens, David Christopher Fisher, Owen A. O’Connor, Jeff Porter Sharman and Yasuhiro Oki. Their work appears in journals such as Blood, Hematological Oncology, Journal of Clinical Oncology, Blood Advances and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.